In a mouse model of tamoxifen-inducible liver cancer, tumor-specific CD8+ T cells, or TST cells, were determined to be dysfunctional early during tumorigenesis, suggesting that T cell dysfunction in later stages of cancer may be established during the initial tumor formation [87]. The gene discussed is CD8A; the disease is neoplasm.